Reinheim
Germany
44
2017-07-06
The entities that hold a legal rights for patent applications filed by inventor BEIER Norbert:
Norbert BEIER from Reinheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and β-cell dysfunction
#2 | 2011-09-15Difluorophenyldiacylhydrazide derivatives
#3 | 2011-08-113-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors
#4 | 2011-08-04Heterocyclic indazole derivatives
#5 | 2011-06-16Oxadiazole derivatives for the treatment of diabetes
#6 | 2011-03-10PHARMACEUTICAL COMPOSITION COMPRISING RIMEPORIDE FOR TREATING DISEASES ASSOCIATED WITH INSULIN RESISTANCE AND BETA-CELL DYSFUNCTION
#7 | 2011-03-10SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas
#8 | 2011-02-03Glucopyranoside derivatives
#9 | 2011-01-135-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2
#10 | 2011-01-13CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES
#11 | 2010-12-30Beta-amino acid derivatives for treatment of diabetes
#12 | 2010-12-30Glucokinase Activators
#13 | 2010-12-023-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes
#14 | 2010-09-30Imidazo 1,2-pyrimidine derivatives for the treatment of diseases such as diabetes
#15 | 2010-08-26Pyridine derivatives useful as glucokinase activators
#16 | 2010-08-19N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
#17 | 2010-03-115-(1,3,4-OXADIAZOL-2-YL)-1H-INDAZOLE AND 5-(1,3,4-THIADIAZOL-2-YL)-1H-INDAZOLE DERIVATIVES AS SGK INHIBITORS FOR THE TREATMENT OF DIABETES
#18 | 2010-02-11Indolizine derivatives and the use thereof as antidiabetics
#19 | 2010-01-21Benzimidazole derivatives
#20 | 2009-10-08Aminoindazolylurea derivatives
#21 | 2009-09-03Mandelic hydrazides
#22 | 2009-03-19Indazole-heteroaryl derivatives
#23 | 2009-02-05AMINO INDAZOLE DERIVATIVES
#24 | 2009-02-05Indazolesquaric Acid Derivatives as Chk1, Chk2 and Sgk Inhibitors
#25 | 2009-02-034-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1,2,4)triazin-5-one derivatives having a PDE-IV inhibiting and TNF-antagonistic effect for the treatment of cardiac diseases and allergies
#26 | 2008-10-23Squaric Acid Derivatives
#27 | 2008-09-253-Oxoindazolesquaric Acid Derivatives
#28 | 2008-09-04ACYLHYDRAZONE DERIVATIVES AND THE USE THEREOF IN THE INHIBITION, REGULATION AND/OR MODULATION OF KINASE SIGNAL TRANSDUCTION
#29 | 2008-07-10Acyl hydrazines as kinase inhibitors, in particular for SGK
#30 | 2008-04-17Heterocyclic carbonyl compounds
#31 | 2008-02-07Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides
#32 | 2007-12-25Pyrimidine derivatives
#33 | 2007-12-25Benzoylpyridazines
#34 | 2007-10-043-aminoindazoles
#35 | 2007-08-212-Aminoalkyl-thieno[2,3-d]pyrimidines
#36 | 2007-03-15Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction
#37 | 2006-11-30Hydrazono-malonitriles
#38 | 2006-11-28Hydrazono-malonitriles
#39 | 2006-09-14Aryl oximes
#40 | 2006-06-135-aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect
#41 | 2006-03-28Sulfamidothienopyrimidines
#42 | 2005-09-22Aryl oximes
#43 | 2005-05-262-Guanidino-4-heterocyclylquinazolines
#44 | 2005-03-31Use of type 4 phosphodiesterase inhibitors in myocardial diseases
1920510 ⎘